Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid

Clinical Pharmacology and Therapeutics
R H LevyP Loiseau

Abstract

The incidence of valproic acid hepatotoxicity has been reported to increase in patients who are receiving polytherapy. A minor valproic acid metabolite, 2-propyl-4-pentenoic acid (4-ene-VPA), formed by a cytochrome P450-mediated reaction, has been shown to be a potent inducer of microvesicular steatosis in rats. This study tested the hypothesis that formation of 4-ene-VPA would be increased in patients taking valproic acid with carbamazepine or with phenytoin but decreased with coadministration of an inhibitor of cytochrome P450 (the antiepileptic drug stiripentol in 300 to 1200 mg daily doses) in healthy subjects. Blood and urine samples in the studies were collected during a dosing interval at steady state. Valproic acid was assayed in plasma by capillary gas chromatography; valproic acid and 15 metabolites were measured in urine by gas chromatography/mass spectrometry. The formation clearance (CLf) of 4-ene-VPA was increased twofold in the valproic acid-carbamazepine and valproic acid-phenytoin groups. In the valproic acid/stiripentol studies, the CLf of 4-ene-VPA decreased by 32% in the 1200 mg/day stiripentol study. Similar findings were obtained at 600 and 300 mg/day stiripentol. These findings provide evidence supporting...Continue Reading

Citations

Jul 1, 1992·Epilepsia·G D AndersonR H Levy
Feb 11, 2005·The Annals of Pharmacotherapy·Francisco Javier Coves-OrtsFrancisco Palacios-Ortega
Mar 8, 2005·Drug Metabolism Reviews·Shufeng ZhouYu-Zong Chen
Jul 19, 2005·Expert Opinion on Investigational Drugs·Catherine Chiron
Sep 7, 2011·Drug Metabolism Reviews·Dominique PessayreAbdellah Mansouri
Aug 1, 1996·Clinical Pharmacology and Therapeutics·G D AndersonA T Dren
Feb 13, 2009·Expert Opinion on Drug Metabolism & Toxicology·Stanislaw J CzuczwarMarek Kacinski
Sep 11, 2010·Biopharmaceutics & Drug Disposition·Sophie L ReganB Kevin Park
Jul 7, 2010·Toxicology Mechanisms and Methods·Noushin Amini-ShiraziAbbas Kebriaeezadeh
Jun 19, 1992·Pharmaceutisch Weekblad. Scientific Edition·J R Stephens, R H Levy
Apr 1, 1997·Journal of Clinical Psychopharmacology·W C WirshingA Sun
Sep 14, 2001·European Journal of Drug Metabolism and Pharmacokinetics·U KreherF Wien
Apr 9, 2008·Journal of Inherited Metabolic Disease·M F B SilvaI Tavares de Almeida
Feb 19, 2016·Expert Opinion on Drug Metabolism & Toxicology·Alberto VerrottiPasquale Parisi
Nov 10, 2017·Current Neuropharmacology·Katalin MonostoryGábor Csukly
Jun 19, 1992·Pharmaceutisch Weekblad. Scientific Edition·T A Baillie
Nov 8, 2007·The Journal of Pharmacology and Experimental Therapeutics·Andrea Caroline KnappStephan Krähenbühl
Jun 26, 2009·Epilepsia·Yushi InoueShunya Ikeda
Apr 1, 2008·Expert Opinion on Drug Discovery·Stanislaw J CzuczwarMarek Kacinski
Jan 1, 1995·Pharmacology & Therapeutics·B Fromenty, D Pessayre
Jan 1, 1995·Pharmacology & Therapeutics·B K ParkN R Kitteringham
Jun 1, 1994·Toxicology in Vitro : an International Journal Published in Association with BIBRA·R L FisherK Brendel
Sep 8, 2005·Psychosomatics·Neil B SandsonKelly L Cozza
Jul 16, 2019·Chemical Research in Toxicology·Matthew K MatlockS Joshua Swamidass
Feb 1, 1994·The Journal of Pediatrics·S G KahlerJ V Leonard

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.